Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday.
"The first batch of Sputnik vaccine is expected to be produced at SII&rsquo;s facilities in September," RDIF said in a statement.
The parties intend to produce over 300 million doses of the vaccine in India per year, it added.
"As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun," RDIF said.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

The parties intend to produce over 300 million doses of the vaccine in India per year

Serum Institute to start manufacturing Sputnik Covid-19 vaccine in September

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast

Home / News / India News / Article / Serum Institute to start manufacturing Sputnik Covid-19 vaccine in September

Serum Institute to start manufacturing Sputnik Covid-19 vaccine in September

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast